See more : Atlantic Union Bankshares Corporation (AUB) Income Statement Analysis – Financial Results
Complete financial analysis of HH Biotechnology Holdings Company (HHBT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of HH Biotechnology Holdings Company, a leading company in the Real Estate – Services industry within the Real Estate sector.
- Westshore Terminals Investment Corporation (WTSHF) Income Statement Analysis – Financial Results
- OneMedNet Corporation (ONMDW) Income Statement Analysis – Financial Results
- AB Industrivärden (publ) (IDTVF) Income Statement Analysis – Financial Results
- Pan Global Resources Inc. (PGNRF) Income Statement Analysis – Financial Results
- KAINOS Laboratories, Inc. (4556.T) Income Statement Analysis – Financial Results
HH Biotechnology Holdings Company (HHBT)
About HH Biotechnology Holdings Company
HH Biotechnology Holdings Company engages in health and green industries. It focuses on planting and supplying macadamia nuts for use in foods, cooking oils, healthy products, toiletries, and cosmetics. The company was formerly known as Great China International Holdings, Inc. and changed its name to HH Biotechnology Holdings Company in August 2016. HH Biotechnology Holdings Company was incorporated in 1987 and is headquartered in Shenyang, the People's Republic of China.
| Metric | 2015 |
|---|---|
| Revenue | 7.99M |
| Cost of Revenue | 5.64M |
| Gross Profit | 2.35M |
| Gross Profit Ratio | 29.45% |
| Research & Development | 0.00 |
| General & Administrative | 0.00 |
| Selling & Marketing | 0.00 |
| SG&A | 0.00 |
| Other Expenses | 745.36K |
| Operating Expenses | -745.36K |
| Cost & Expenses | 5.77M |
| Interest Income | 0.00 |
| Interest Expense | 874.33K |
| Depreciation & Amortization | 3.22M |
| EBITDA | 5.44M |
| EBITDA Ratio | 79.07% |
| Operating Income | 3.10M |
| Operating Income Ratio | 38.78% |
| Total Other Income/Expenses | -443.45K |
| Income Before Tax | 2.66M |
| Income Before Tax Ratio | 33.23% |
| Income Tax Expense | 230.99K |
| Net Income | 2.48M |
| Net Income Ratio | 30.99% |
| EPS | 0.18 |
| EPS Diluted | 0.18 |
| Weighted Avg Shares Out | 13.52M |
| Weighted Avg Shares Out (Dil) | 13.52M |
Source: https://incomestatements.info
Category: Stock Reports